I may have felt a little nausea here and there, but nothing like I did the first week
Identifying and addressing these conditions can be key to achieving a healthier BMI
What the research actually shows Feb 18, 2026 Feb 18, 2026 Does tirzepatide give you energy
Tirzepatide (Mounjaro, Zepbound) is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management and chronic weight management
Other manifestations include decreased insulin secretion, increased insulin resistance and increased blood sugar levels [86]
This includes support for individuals who are overweight or obese, those with cardiovascular disease risk factors, diabetes, hypertension, kidney disease, eating disorders, and more